chr18-6868226-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001366230.1(ARHGAP28):c.803C>T(p.Ala268Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000057 in 1,613,774 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001366230.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGAP28 | NM_001366230.1 | c.803C>T | p.Ala268Val | missense_variant | 6/18 | ENST00000383472.9 | NP_001353159.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGAP28 | ENST00000383472.9 | c.803C>T | p.Ala268Val | missense_variant | 6/18 | 5 | NM_001366230.1 | ENSP00000372964 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251432Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135886
GnomAD4 exome AF: 0.0000452 AC: 66AN: 1461610Hom.: 1 Cov.: 30 AF XY: 0.0000550 AC XY: 40AN XY: 727112
GnomAD4 genome AF: 0.000171 AC: 26AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2023 | The c.326C>T (p.A109V) alteration is located in exon 5 (coding exon 4) of the ARHGAP28 gene. This alteration results from a C to T substitution at nucleotide position 326, causing the alanine (A) at amino acid position 109 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at